ESC 365 - Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal PRO

EHRA Premium Access

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal PRO

Session: Tough decisions in anticoagulation in atrial fibrillation

Topic: Stroke Prevention in Cardioversion

Event: EHRA 2018

Congress Presentation

Add to my library

11 more presentations in this session

Opening question

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism- PRO

Speaker: Doctor S. Themistoclakis (Venice, IT)

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - CON

Speaker: Associate Professor T. Potpara (Belgrade, RS)

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal CON

Chairperson conclusion & Closing question

Access the full session

Tough decisions in anticoagulation in atrial fibrillation

Speakers: Doctor S. Themistoclakis, Associate Professor T. Potpara

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources